hrcak mascot   Srce   HID

Pregledni rad
https://doi.org/10.2478/v10007-010-0037-4

Ordered mesoporous silicates as matrices for controlled release of drugs

TINA UKMAR ; National Institute of Chemistry, Slovenia, 1001 Ljubljana, Slovenia
ODON PLANINŠEK ; University of Ljubljana, Faculty of Pharmacy, 1000 Ljubljana, Slovenia

Puni tekst: engleski, pdf (255 KB) str. 373-385 preuzimanja: 665* citiraj
APA 6th Edition
UKMAR, T. i PLANINŠEK, O. (2010). Ordered mesoporous silicates as matrices for controlled release of drugs. Acta Pharmaceutica, 60 (4), 373-385. https://doi.org/10.2478/v10007-010-0037-4
MLA 8th Edition
UKMAR, TINA i ODON PLANINŠEK. "Ordered mesoporous silicates as matrices for controlled release of drugs." Acta Pharmaceutica, vol. 60, br. 4, 2010, str. 373-385. https://doi.org/10.2478/v10007-010-0037-4. Citirano 16.06.2019.
Chicago 17th Edition
UKMAR, TINA i ODON PLANINŠEK. "Ordered mesoporous silicates as matrices for controlled release of drugs." Acta Pharmaceutica 60, br. 4 (2010): 373-385. https://doi.org/10.2478/v10007-010-0037-4
Harvard
UKMAR, T., i PLANINŠEK, O. (2010). 'Ordered mesoporous silicates as matrices for controlled release of drugs', Acta Pharmaceutica, 60(4), str. 373-385. doi: https://doi.org/10.2478/v10007-010-0037-4
Vancouver
UKMAR T, PLANINŠEK O. Ordered mesoporous silicates as matrices for controlled release of drugs. Acta Pharm. [Internet]. 2010 [pristupljeno 16.06.2019.];60(4):373-385. doi: https://doi.org/10.2478/v10007-010-0037-4
IEEE
T. UKMAR i O. PLANINŠEK, "Ordered mesoporous silicates as matrices for controlled release of drugs", Acta Pharmaceutica, vol.60, br. 4, str. 373-385, 2010. [Online]. doi: https://doi.org/10.2478/v10007-010-0037-4

Sažetak
Interest in and thereby also in development of ordered mesoporous silicates as drug delivery devices have grown immensely over the past few years. On hand selected cases from the literature, the power of such systems as delivery devices has been established. Specifically, it is shown how it is possible to enhance the release kinetics of poorly soluble drugs by embedding them in mesoporous silicates. Further critical factors governing the structure and release of the model drug itraconazole incorporated in an SBA-15 matrix are briefly reviewed. The possibility of functionalizing the surface of mesoporous matrices also under harsher conditions offers a broad platform for the design of stimuli-responsive drug release, including pH responsive systems and systems which respond to the presence of specific ions, reducing agents, magnetic field or UV light, whose efficiency and biocompatibility has been established in vitro.

Ključne riječi
mesoporous silicates; drug delivery; modified release

Hrčak ID: 59505

URI
https://hrcak.srce.hr/59505

[slovenski]

Posjeta: 917 *